The extrinsic resistance is caused by the activation of an angiogenic switch, leading either to up-regulation of the VEGF pathway, the recruitment of alternative factors responsible for tumor revascularization [17], or alternatively, to the sequestration of sunitinib in lysosomes, which reduces its bioavailability [18]. Here, VEGFA is linked to neoplasm.